<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ABB</journal-id><journal-title-group><journal-title>Advances in Bioscience and Biotechnology</journal-title></journal-title-group><issn pub-type="epub">2156-8456</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/abb.2013.41008</article-id><article-id pub-id-type="publisher-id">ABB-26958</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Antioxidant activity of Bios-p peptide analogue in HEK293T cells and three-dimensional structure prediction
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>amela</surname><given-names>Fernández Manzano</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ignacio</surname><given-names>Jofré Fernández</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fabiola</surname><given-names>Zambrano</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Patricia</surname><given-names>Navarrete Gómez</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Magdalena</surname><given-names>Cuevas Troncoso</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ximena</surname><given-names>Romo Marty</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Andrés</surname><given-names>Ávila Barrera</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Fernando</surname><given-names>Romero Mejía</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Centro de Modelación y Computación Científica, Universidad de La Frontera, Temuco, Chile</addr-line></aff><aff id="aff2"><addr-line>Departamento de Ciencias Biologicas, Facultad de Ciencias Biologicas, Universidad Andres Bello, Talcahuano, Chile</addr-line></aff><aff id="aff1"><addr-line>Center of Neurosciences and Peptides Biology, Universidad de La Frontera, Temuco, Chile</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>magdalenacuevas@ufro.cl(MCT)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>17</day><month>01</month><year>2013</year></pub-date><volume>04</volume><issue>01</issue><fpage>55</fpage><lpage>61</lpage><history><date date-type="received"><day>25</day>	<month>October</month>	<year>2012</year></date><date date-type="rev-recd"><day>27</day>	<month>November</month>	<year>2012</year>	</date><date date-type="accepted"><day>17</day>	<month>January</month>	<year>2013</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Studies had indicate that excessive production of reactive oxygen species (ROS) affect cellular signaling pathways, which is associated with pathological and physiological conditions such as cancer, diabetes and neurodegenerative diseases In this context, our laboratory has obtained the Bios-p, a ROS modulator, peptide analogue by sequencing from the seed of Bauhinia bauhinoides, which represents the active 12-amino acid, obtained from the inhibitor BbKI protease and we predicted the three-dimensional structure of Bios-p analogue peptide using homology modeling, being patented by the working group of Dr. Maria Luiza Vilela Oliva of UNIFESP, Brazil (a member of our cluster). The protective effect on the viability and antioxidant capacity of Bios-p was studied in HEK 293T cells under oxidative stress induced by hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) using SYTOXGREEN/DHE and luminescence assay. The three-dimensional structure of Bios-p peptide analogue was predicted by homology-based modeling using Modeller9v8. The pretreatment with different concentrations of Bios-p (1 μM - 10 μM) showed an increase of 53.83% &#177; 3.86% the cellular viability in under oxidative stress compared to control. Furthermore, the results to indicate that HEK293T cells by incubating for 24 h with Bios-p shown a significant decreased of basal extracellular ROS on total cell population in 89.67% &#177; 0.76%, compared to control in the absence of the analogue. Similarly it is observed that Bios-p has a significant antioxidant effect on extracellular ROS production when cells are subjected to oxidative stress induced by 200 μM H<sub>2</sub>O<sub>2 </sub>in<sub> </sub>64.37% &#177; 4.63%, compared to control in absence of H<sub>2</sub>O<sub>2 </sub>and Bios-p. 
  These results suggest that Bios-p has potential as antioxidant agent in cells HEK293T under H<sub>2</sub>O<sub>2</sub>-induced oxidative stress and that can protect the cells viability as concentration-dependent, and we propose a new biotechnological tool for modulate the ROS production. 
 
</p></abstract><kwd-group><kwd>Antioxidant; Bios-p; &lt;i&gt;Bauhinia bauhinoides&lt;/i&gt;</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. INTRODUCTION</title><p>The excessive production of reactive oxygen species (ROS) affect cellular signaling pathways, which is associated with pathological and physiological conditions such as cancer, diabetes and neurodegenerative diseases [<xref ref-type="bibr" rid="scirp.26958-ref1">1</xref>] . Cellular defense mechanisms against oxidative damage include enzymatic conversion of ROS (e.g., <img src="8-7300396\e9b643a9-e4b6-4754-bb9d-d66ddb7548be.jpg" />and OH<sup>−</sup>) into less reactive species, chelation of transition metal catalysts and detoxiﬁcation of ROS by antioxidants [<xref ref-type="bibr" rid="scirp.26958-ref2">2</xref>] . Thus, application of antioxidants might be an effective therapeutic strategy to cure neurodegenerative disorders initiated by ROS. Because of this, there is growing interest in the scientific community and industry to obtain naturally occurring substances aimed at the prevention and treatment of these pathologies.</p><p>It has also reported a number of possible bioactivities that might have, including antimicrobial capacity, hypertensive, antioxidant and anticancer [<xref ref-type="bibr" rid="scirp.26958-ref3">3</xref>]. Accordingly, biotechnological products are among various naturally occurring substances that are receiving growing attention from the viewpoint of antioxidation. The antioxidant peptides can be isolated from different sources such as marine sources [<xref ref-type="bibr" rid="scirp.26958-ref4">4</xref>] and plants [<xref ref-type="bibr" rid="scirp.26958-ref5">5</xref>]. Some of them have been accepted to be one of the important candidates for the development of effective and non-toxic medicines with antioxidant actions. The presence of His (H) within the peptide sequence is characteristic of antioxidant peptides, together with the presence at the N-terminal residues Leu (L) or Pro (P) [<xref ref-type="bibr" rid="scirp.26958-ref6">6</xref>]. According to the findings by Chan and Decker (1994) [<xref ref-type="bibr" rid="scirp.26958-ref7">7</xref>], the structure-activity relationship of antioxidants in their own sequence His, is attributed to the ability of hydrogen donation and/or metal chelation capacity of the imidazole group.</p><p>The plants, the subject of a growing number of natural product researches, are now considered as efﬁcient producers of biologically active and/or chemically novel compounds. One source plants used for extraction of bioactive polypeptides is the genus Bauhinia, which has more than 600 species of wide distribution in tropical and subtropical forests [<xref ref-type="bibr" rid="scirp.26958-ref8">8</xref>]. Many proteins have been isolated from its seeds, and in particular bauhinioides species [<xref ref-type="bibr" rid="scirp.26958-ref9">9</xref>] . Thus, functional and biologically active peptides and derivatives obtained from seeds, as well as being a contribution to their nutritional value, have the ability to exert physiological functions that native protein sequenced from a large active, can be obtained by scalable production processes industrial, or by synthesis, by fermentation or by methods of recombinant protein. In this context, our laboratory has utilized the Bios-p peptide analogue, which represents the active 12-amino acid active site, obtained by sequencing from the inhibitor BbKI protease present in the seed of Bauhinia bauhinoides and patented by the working group of Dr. Maria Luiza Vilela Oliva of UNIFESP, Brazil. In this study we investigated the protector effect and antioxidant capacity of Bios-p peptide in the cellular model HEK293T when these were subjected to oxidative stress induced by hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>). On the other hand, it is known that the function of the bioactive peptide is dependent on its amino acid sequence and three dimensional structures that these possess [<xref ref-type="bibr" rid="scirp.26958-ref10">10</xref>] and binding with cell membrane components. Because of this, we have obtained a threedimensional structure of Bios-p using modeling basedhomology.</p></sec><sec id="s2"><title>2. MATHERIALS AND METHODS</title><sec id="s2_1"><title>2.1. Cellular Lines and Culture Conditions</title><p>HEK293 cells were cultured in D-MEM medium supplemented with 10% FBS (Hyclone) and penicilin-streptomicin 1% (Invitrogen). Cell growth was done at 5% CO<sub>2</sub> and 37˚C changing the culture medium every three days.</p></sec><sec id="s2_2"><title>2.2. Incubation of HEK293T Cells with Bios-p Peptide Analogue</title><p>The cells were grown during 24 h in six-well plates and allowed to reach to 50% confluence. Then, were incubated with Bios-p analogue peptide at different concentrations of 0,1; 1 and 10 &#181;g/ml during 24 h at 37˚C. Additionally cells were treated with H<sub>2</sub>O<sub>2</sub> 200 &#181;M for 15 min at 37˚C to induce the oxidative stress.</p></sec><sec id="s2_3"><title>2.3. Cells-Viability Assessment</title><p>The cells were incubated with the probe SYTOX Green 0.5 &#181;M (Molecular Probes, Eugene, OR) at 37˚C for 15 min in darkness. The cells were analyzed in a confocal microscope at 510 nm emission of SYTOX Green. The percentage of viable cells was calculated by manually counting the number in the x-y reference frame visualized in ten different fields.</p></sec><sec id="s2_4"><title>2.4. Production of ROS Extracellular</title><p>The production of ROS extracellular were measured by luminescence assay by incubating the cells with luminol 200 &#181;M (5-amino-2, 3 hydro-1, 4-ftalazinediona, Sigma Chemical Co., St. Louis, MO) for 15 min at 37˚C in darkness and immediately quantifying the luminescence in a luminometer Luminoskan mark (Thermos Scientifics, China), expressing the results as relative luminescence units (RLU). In each analysis, a negative control without the addition of luminol and positive control cells treated with H<sub>2</sub>O<sub>2</sub> 200 &#181;M, were added.</p></sec><sec id="s2_5"><title>2.5. Anion Superoxide Intracellular Production</title><p>The cells were incubated with the probes DHE/SYTOX Green (2 &#181;M and 0.5 &#181;M respectively) (Molecular probes, Eugene, OR) at 37˚C for 15 min in darkness. The results obtained with this probe have been validated as a measure of the ability of cells to generate ROS, specifically definitive identification of the superoxide anion. The cells were analyzed in a confocal microscope at 510 and 670 nm emissions of SYTOX Green and DHE, respectively [<xref ref-type="bibr" rid="scirp.26958-ref11">11</xref>]. The percentage of viable cells producing superoxide anion was calculated by manually counting the number in the x-y reference frame, and dividing by the total number of cells visualized in ten different fields.</p></sec><sec id="s2_6"><title>2.6. Homology Modeling</title><p>The three-dimensional structure of Bios-p peptide analogue was predicted by homology-based modeling using Modeller9v8 [<xref ref-type="bibr" rid="scirp.26958-ref12">12</xref>]. BLAST-P was used to identify the potential template structures for molecular modeling. The templates are in Protein Data Bank (PDB) WEB page, with PDB IDs 2GO2/2GZB. The protein models were validated using prochek [<xref ref-type="bibr" rid="scirp.26958-ref13">13</xref>] and Anolea [<xref ref-type="bibr" rid="scirp.26958-ref14">14</xref>].</p></sec><sec id="s2_7"><title>2.7. Statistical Analysis</title><p>The data for the different functional parameters evaluated were expressed as mean + SEM. The data were analyzed with GraphPad Prism version 5.02 for Windows (GraphPad Software, San Diego, CA, USA). The differences between the groups were analyzed using the one way analysis of variance (ANOVA) followed by Tukey multiple comparison tests. P values &lt; 0.05 were considered as significant.</p></sec></sec><sec id="s3"><title>3. RESULTS AND DISCUSSION</title><sec id="s3_1"><title>3.1. Bios-p Protects the Cells-Viability</title><p>Was evaluated the protective effect of Bios-p peptide analog against H<sub>2</sub>O<sub>2</sub>-induced cytotoxicity in the HEK 293T cellular model (<xref ref-type="fig" rid="fig1">Figure 1</xref>). When added to cell culture H<sub>2</sub>O<sub>2</sub> 200 &#181;M without pre-treatment with Bios-p, was observed a decreased of cell viability product of H<sub>2</sub>O<sub>2</sub>-cytoxicity. However, the pre-treatment with different concentrations of Bios-p (1 - 10 μM) showed a increase of 53.83% &#177; 3.86% the cellular viability in under oxidative stress compared to control. As shown in the <xref ref-type="fig" rid="fig1">Figure 1</xref>(a), the protective effect on the viability of Bios-p is concentration-dependent (P &lt; 0.05). Additionally, we determined the effective concentration of Bios-p to maintain viable cells by 50% (EC<sub>50</sub>) when these are subjected to H<sub>2</sub>O<sub>2</sub>-induced oxidative stress. The EC<sub>50</sub> was determined in 7.51 &#181;M &#177; 0.09 &#181;M.</p><p>Furthermore, we directly examined the viability effect when the cells were pretreatment with the EC<sub>50</sub> of Bios-p (7.51 &#181;M) during 6-12-18 and 24 h. As shown in the</p><p><xref ref-type="fig" rid="fig1">Figure 1</xref>(b) the incubation with Bios-p significantly increased the viability cells (P &lt; 0.05) when the cells are under oxidative stress with H<sub>2</sub>O<sub>2</sub>. Moreover, the results show that by incubating the cells at 37˚C during 6, 12, 18 and 24 h with Bios-p (7.51 &#181;M), was not observed a significant effect on the protection of viability respect to control in the absence of Bios-p when these cells are not in conditions of oxidative stress (P &gt; 0.05).</p></sec></sec></body><back><ref-list><title>References</title><ref id="scirp.26958-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Ajila, C.M. and Prasada Rao U.J. (2008) Protection against hydrogen peroxide induced oxidative damage in rat erythrocytes by Mangifera indica L. peel extract. Food and Chemical Toxicology, 46, 303-309. 
doi:10.1016/j.fct.2007.08.024</mixed-citation></ref><ref id="scirp.26958-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Ames, B.N., M.K. Shigenaga, and T.M. Hagen (1993) Oxidants, antioxidants, and the degenerative diseases of aging. Proceedings of the National Academy of Sciences of the United States, 90, 7915-7922. 
doi:10.1073/pnas.90.17.7915</mixed-citation></ref><ref id="scirp.26958-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Korhonen, H. and A. Pihlanto (2003) Food-derived bioactive peptides—Opportunities for designing future foods. Current Pharmaceutical Design, 9, 1297-1308.  
doi:10.2174/1381612033454892</mixed-citation></ref><ref id="scirp.26958-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Neves, S.A., et al. (2001) Neutrophil migration induced in vivo and in vitro by marine algal lectins. Inflammation Research, 50, 486-490. doi:10.1007/PL00000222</mixed-citation></ref><ref id="scirp.26958-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Megias, C., et al. (2004) Purification of an ACE inhibittory peptide after hydrolysis of sunflower (Helianthus annuus L.) protein isolates. Journal of Agricultural and Food Chemistry, 52, 1928-1932.  
doi:10.1021/jf034707r</mixed-citation></ref><ref id="scirp.26958-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Chen, J.Y., et al. (1998) α-Tocopherol Content and Oxidative Stability of Egg Yolk as Related to Dietary α-Tocopherol. Journal of Food Science, 63, 919-922.  
doi:10.1111/j.1365-2621.1998.tb17927.x</mixed-citation></ref><ref id="scirp.26958-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Chan, K.M. and E.A. Decker (1994) Endogenous skeletal muscle antioxidants. Critical Reviews in Food Science and Nutrition, 34, 403-426. 
doi:10.1080/10408399409527669</mixed-citation></ref><ref id="scirp.26958-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Vaz, A.M.S.F. and Tozzi, A.M.G.A. (2005) Sinopse de Bauhinia sect. Pauletia (Cav.) DC. (Leguminosae: Caesalpinioideae: Cercideae) no Brasil. Revista Brasileira de Botanica, 28, 477-491.  
doi:10.1590/S0100-84042005000300006</mixed-citation></ref><ref id="scirp.26958-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Cagliari, C.I., et al. (2003) Action of Bauhinia bauhinioides synthetic peptides on serine proteinases. Biochemical and Biophysical Research Communications, 311, 241-245. doi:10.1016/j.bbrc.2003.09.203</mixed-citation></ref><ref id="scirp.26958-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Se-Kwon, K., et al. (2011) Proteins and Peptides as antioxidants, in bioactive food proteins and peptides. CRC Press, Boca Raton, 97-116.</mixed-citation></ref><ref id="scirp.26958-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Fink, B., et al. (2004) Detection of intracellular superoxide formation in endothelial cells and intact tissues using dihydroethidium and an HPLC-based assay. American Journal of Physiology—Cell Physiology, 28, C895-C902. 
doi:10.1152/ajpcell.00028.2004</mixed-citation></ref><ref id="scirp.26958-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Eswar, N., et al. (2006) Comparative protein structure modeling using Modeller. Current Protocols in Bioinformatics—Current Protocols, Chapter 5, Unit 5-6.</mixed-citation></ref><ref id="scirp.26958-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Laskowski, R.A., et al. (1993) PROCHECK: A program to check the stereochemical quality of protein structures. Journal of Applied Crystallography, 26, 283-291.  
doi:10.1107/S0021889892009944</mixed-citation></ref><ref id="scirp.26958-ref14"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Melo</surname><given-names> F.</given-names></name>,<name name-style="western"><surname> et al. </surname><given-names>  </given-names></name>,<etal>et al</etal>. (<year>1997</year>)<article-title>ANOLEA: A www server to assess protein structures</article-title><source> Proceedings International Conference on Intelligent Systems for Molecular Biology</source><volume> 5</volume>,<fpage> 187</fpage>-<lpage>190</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.26958-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Villegas, J., et al. (2005) Influence of reactive oxygen species produced by activated leukocytes at the level of apoptosis in mature human spermatozoa. Fertility and Sterility, 83, 808-810.  
doi:10.1016/j.fertnstert.2004.09.022</mixed-citation></ref><ref id="scirp.26958-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Blanchetot, C. and J. Boonstra (2008) The ROS-NOX connection in cancer and angiogenesis. Critical Reviews in Eukaryotic Gene Expression, 18, 35-45. 
doi:10.1615/CritRevEukarGeneExpr.v18.i1.30</mixed-citation></ref><ref id="scirp.26958-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Hansen, D., et al. (2007) Crystal structure of a novel cysteinless plant Kunitz-type protease inhibitor. Biochemical and Biophysical Research Communications, 360, 735-740. doi:10.1016/j.bbrc.2007.06.144</mixed-citation></ref><ref id="scirp.26958-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Vitkup, D., et al. (2001) Completeness in structural genomics. Nature Structural &amp; Molecular Biology, 8, 559-566. doi:10.1038/88640</mixed-citation></ref></ref-list></back></article>